Proteomics

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Proteomics continues to grow in relevance and technical complexity as its importance in the investigation and understanding of protein expression in disease and drug development is recognized. Advances in proteomics have been supported by the continued expansion and availability of pharmacologically relevant genome information and driven by numerous and diverse technological and bioinformatic developments that underscore the complexity of the proteome. This chapter addresses some of the various technologies included in proteomic approaches, and provides salient examples where these technologies have been applied to pharmacology and/or the process of drug development.

Original languageEnglish (US)
Title of host publicationPharmacogenomics, Second Edition
PublisherCRC Press
Pages413-440
Number of pages28
ISBN (Electronic)9780849359507
ISBN (Print)1574448781, 9781574448788
StatePublished - Jan 1 2005

Fingerprint

Proteomics
Technology
Proteome
Bioinformatics
Computational Biology
Pharmaceutical Preparations
Genes
Availability
Genome
Pharmacology
Proteins

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Witzmann, F., & Wang, M. (2005). Proteomics. In Pharmacogenomics, Second Edition (pp. 413-440). CRC Press.

Proteomics. / Witzmann, Frank; Wang, Mu.

Pharmacogenomics, Second Edition. CRC Press, 2005. p. 413-440.

Research output: Chapter in Book/Report/Conference proceedingChapter

Witzmann, F & Wang, M 2005, Proteomics. in Pharmacogenomics, Second Edition. CRC Press, pp. 413-440.
Witzmann F, Wang M. Proteomics. In Pharmacogenomics, Second Edition. CRC Press. 2005. p. 413-440
Witzmann, Frank ; Wang, Mu. / Proteomics. Pharmacogenomics, Second Edition. CRC Press, 2005. pp. 413-440
@inbook{8e934b27256c4047a377fb9ef930889f,
title = "Proteomics",
abstract = "Proteomics continues to grow in relevance and technical complexity as its importance in the investigation and understanding of protein expression in disease and drug development is recognized. Advances in proteomics have been supported by the continued expansion and availability of pharmacologically relevant genome information and driven by numerous and diverse technological and bioinformatic developments that underscore the complexity of the proteome. This chapter addresses some of the various technologies included in proteomic approaches, and provides salient examples where these technologies have been applied to pharmacology and/or the process of drug development.",
author = "Frank Witzmann and Mu Wang",
year = "2005",
month = "1",
day = "1",
language = "English (US)",
isbn = "1574448781",
pages = "413--440",
booktitle = "Pharmacogenomics, Second Edition",
publisher = "CRC Press",

}

TY - CHAP

T1 - Proteomics

AU - Witzmann, Frank

AU - Wang, Mu

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Proteomics continues to grow in relevance and technical complexity as its importance in the investigation and understanding of protein expression in disease and drug development is recognized. Advances in proteomics have been supported by the continued expansion and availability of pharmacologically relevant genome information and driven by numerous and diverse technological and bioinformatic developments that underscore the complexity of the proteome. This chapter addresses some of the various technologies included in proteomic approaches, and provides salient examples where these technologies have been applied to pharmacology and/or the process of drug development.

AB - Proteomics continues to grow in relevance and technical complexity as its importance in the investigation and understanding of protein expression in disease and drug development is recognized. Advances in proteomics have been supported by the continued expansion and availability of pharmacologically relevant genome information and driven by numerous and diverse technological and bioinformatic developments that underscore the complexity of the proteome. This chapter addresses some of the various technologies included in proteomic approaches, and provides salient examples where these technologies have been applied to pharmacology and/or the process of drug development.

UR - http://www.scopus.com/inward/record.url?scp=85057655655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057655655&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85057655655

SN - 1574448781

SN - 9781574448788

SP - 413

EP - 440

BT - Pharmacogenomics, Second Edition

PB - CRC Press

ER -